DE69711661T2 - Micrococcin antibiotika zur prävention und therapie der mastitis - Google Patents

Micrococcin antibiotika zur prävention und therapie der mastitis

Info

Publication number
DE69711661T2
DE69711661T2 DE69711661T DE69711661T DE69711661T2 DE 69711661 T2 DE69711661 T2 DE 69711661T2 DE 69711661 T DE69711661 T DE 69711661T DE 69711661 T DE69711661 T DE 69711661T DE 69711661 T2 DE69711661 T2 DE 69711661T2
Authority
DE
Germany
Prior art keywords
micrococcin
mastitis
milk
antibiotics
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69711661T
Other languages
German (de)
English (en)
Other versions
DE69711661D1 (de
Inventor
Catherine Georges
Edmondson Peel
Bruno Suri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE69711661D1 publication Critical patent/DE69711661D1/de
Application granted granted Critical
Publication of DE69711661T2 publication Critical patent/DE69711661T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/05—Treating milk before coagulation; Separating whey from curd
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
DE69711661T 1996-06-20 1997-06-19 Micrococcin antibiotika zur prävention und therapie der mastitis Expired - Fee Related DE69711661T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810415 1996-06-20
PCT/EP1997/003212 WO1997048408A2 (en) 1996-06-20 1997-06-19 Method for the prevention and treatment of mastitis

Publications (2)

Publication Number Publication Date
DE69711661D1 DE69711661D1 (de) 2002-05-08
DE69711661T2 true DE69711661T2 (de) 2002-10-17

Family

ID=8225635

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69711661T Expired - Fee Related DE69711661T2 (de) 1996-06-20 1997-06-19 Micrococcin antibiotika zur prävention und therapie der mastitis

Country Status (14)

Country Link
US (1) US6187800B1 (enExample)
EP (1) EP0934075B1 (enExample)
JP (1) JP2000513348A (enExample)
CN (1) CN1119170C (enExample)
AT (1) ATE215378T1 (enExample)
AU (1) AU720243B2 (enExample)
BR (1) BR9709812A (enExample)
CA (1) CA2251779A1 (enExample)
DE (1) DE69711661T2 (enExample)
DK (1) DK0934075T3 (enExample)
ES (1) ES2175425T3 (enExample)
IL (1) IL126489A0 (enExample)
PT (1) PT934075E (enExample)
WO (1) WO1997048408A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6638902B2 (en) * 2001-02-01 2003-10-28 Ecolab Inc. Stable solid enzyme compositions and methods employing them
EP1369425A1 (en) * 2001-03-13 2003-12-10 Yamanouchi Pharmaceutical Co. Ltd. Thiopeptide compounds
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
WO2004002451A1 (fr) * 2002-06-28 2004-01-08 Fang Chen Suppositoire a liberation controlee utilise dans un canal secreteur de lait
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ539076A (en) * 2005-03-29 2008-05-30 Blis Technologies Ltd Skin treatment compositions
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
CN100448480C (zh) * 2005-11-09 2009-01-07 北京大北农科技集团股份有限公司 治疗奶牛乳房炎的乳房用无菌粉针制剂及其制备方法
CN101547698B (zh) * 2006-10-10 2014-01-08 威斯康星旧生研究基金会 乳房内乳头密封剂和使用该制剂降低或消除成熟干酪中视觉缺陷的方法
JP5773983B2 (ja) 2009-04-08 2015-09-02 ウィスコンシン アルムニ リサーチ ファンデイション 乳房内乳頭シール剤及びその熟成チーズの外観上の欠陥を減少又は除去のための使用
WO2011046853A1 (en) * 2009-10-12 2011-04-21 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
EP2361632B1 (en) * 2010-02-19 2014-03-19 Protectimmun GmbH Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune diseases
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
RU2662300C2 (ru) * 2013-02-08 2018-07-25 Луода Фарма Пти Лимитед Способы лечения микробных инфекций, в том числе мастита
EP2953623B1 (en) * 2013-02-08 2021-06-30 Luoda Pharma Limited Methods of treating topical microbial infections
TW201607534A (zh) * 2013-10-31 2016-03-01 皮拉馬爾企業有限公司 治療困難梭狀芽孢桿菌相關感染用硫肽化合物
BR112019012804A2 (pt) * 2016-12-27 2020-03-17 Colgate-Palmolive Company Composição antitranspirante/desodorante
GB202014427D0 (en) * 2020-09-14 2020-10-28 Norwegian Univ Of Life Sciences Composition and use
EP4342484A4 (en) * 2021-05-21 2025-04-16 A&J Science Co.,Ltd. Pharmaceutical composition comprising macrocosine compound and method for preparing macrocosine compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2169847C (en) * 1993-08-20 2006-02-14 John Edmondson Peel Method for the prevention and treatment of bovine mastitis

Also Published As

Publication number Publication date
IL126489A0 (en) 1999-08-17
JP2000513348A (ja) 2000-10-10
AU3341097A (en) 1998-01-07
EP0934075B1 (en) 2002-04-03
PT934075E (pt) 2002-08-30
ES2175425T3 (es) 2002-11-16
EP0934075A2 (en) 1999-08-11
DE69711661D1 (de) 2002-05-08
ATE215378T1 (de) 2002-04-15
CN1222081A (zh) 1999-07-07
BR9709812A (pt) 1999-08-10
AU720243B2 (en) 2000-05-25
DK0934075T3 (da) 2002-06-10
CN1119170C (zh) 2003-08-27
CA2251779A1 (en) 1997-12-24
US6187800B1 (en) 2001-02-13
WO1997048408A3 (en) 1998-02-19
WO1997048408A2 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
DE69711661T2 (de) Micrococcin antibiotika zur prävention und therapie der mastitis
US6506400B1 (en) Antiinfective free intramammary veterinary composition
Smith et al. Mastitis and other diseases of the goat's udder
DE69629691T2 (de) Verfahren zur kontrolle von antibiotikaresistenten grampositiven bakterien und behandlung von infektionen
DE3888504T2 (de) Behandlung von Mastitis und Appliziereinrichtung dafür.
Lacy-Hulbert et al. Physical characteristics of the bovine teat canal and their influence on susceptibility to streptococcal infection
US6699907B1 (en) Fatty acid antimicrobial
DE69427492T2 (de) Verfahren zur prävention und behandlung der rindermastitis
RU2367433C1 (ru) Препарат для лечения мастита у коров в период лактации
Barnum et al. An evaluation of a teat dip with dodecyl benzene sulfonic acid in preventing bovine mammary gland infection from experimental exposure to Streptococcus agalactiae and Staphylococcus aureus
EP3004399B1 (de) Probiotische stämme; zusammensetzungen enthaltend probiotische stämme sowie pharmazeutische mittel
Anifantakis Excretion rates of antibiotics in milk of sheep and their effect on yogurt production
RU2028798C1 (ru) Способ профилактики мастита у коров
DE2001671C3 (de) Plyvalentes Mastits-Immunglobulin und dessen Verwendung bei der Bekämpfung der Mastits
Mulchinock Gramicidin in Mastitis Therapy
Ziv et al. Quinaldofur—A New Synthetic Drug for the Treatment of Mastitis: II. Pharmacology, Residues, Udder Irritation and Clinical Efficacy
WO2020106167A1 (en) A formulation for the prevention and treatment of mastitis in dairy animals, in particular cows
DE1185770B (de) Verfahren zur Herstellung eines Heilmittels mit immunbiologischer Wirkung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee